Other current therapy areas
Interested in paediatric endocrinology?
Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.
Three risk factors for CAH hospitalisation identified
Endocrine Society publishes paediatric obesity management guidelines
04-04-2017 | HBV | News | Article
TDF, entecavir efficacy confirmed in real-world HBV cohort
Treatment with a tenofovir disoproxil fumarate-containing regimen or entecavir leads to high virologic and biochemical response rates in patients with chronic hepatitis B virus infection, shows a registry analysis.
31-03-2017 | HBV | News | Article
HBV DNA suppression sustained with switch to tenofovir
Italian research shows that patients with chronic hepatitis B virus infection maintain long-term virologic suppression after switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy, with a low rate of adverse events.